TELUS Ventures co-leads $12 mln financing of Sentrian

Sentrian, a U.S. remote patient Intelligence company, has raised US$12 million in seed-stage and Series A funding. The round was co-led by TELUS Ventures, the strategic venture capital investment arm of Canada's TELUS Communications Co. Other lead investors included Reed Elsevier Ventures and Frost Data Capital. Based in Aliso Viejo, California, Sentrian's platform aims to eliminate preventable hospitalization by leveraging remote biosensors and machine learning to detect patient deterioration early.

CanadaNorth AmericaBriefs